FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386048136> ?p ?o ?g. }

• W4386048136 abstract "Abstract Purpose To evaluate the association between industry payments to physicians related to poly (ADP-ribose) polymerase inhibitors (PARPis) and physicians' prescribing behaviors for PARPis. Methods This cross-sectional study used the publicly accessible Open Payments Database and Medicare Part D database between 2017 and 2021. All physicians who reported more than 10 claims for either olaparib, rucaparib, or niraparib were included in this study. Non-research payments for the PARPis to the physicians from the PARPi manufacturers were extracted from the Open Payments Database. Associations between the physicians’ receipt of payments and likelihood of prescribing PARPis were assessed with logistic generalized estimating equations (GEEs). Dose-response associations between the number of payments and prescription volumes and Medicare expenditures were evaluated with linear GEEs. Results Of the 1,706 eligible physician prescribers, 68.1% received one or more non-research payments related to any of the three PARPis from the manufacturers between 2017 and 2021. Median annual payments per physician were $55 for olaparib, $40 for rucaparib, and $60 for niraparib. Receipt of payments for each PARPi was associated with higher odds of prescribing olaparib (odds ratio [OR]: 1.33 [95% CI: 1.17-1.52], p<0.001), rucaparib (OR: 2.25 [95% CI: 1.72-2.95], p<0.001), and niraparib (OR: 1.45 [95% CI: 1.20-1.76], p<0.001). Dose-response effects were observed between the number of annual payments and the number of prescriptions and/or Medicare expenditures for olaparib and rucaparib. Conclusion Non-research payments to physician prescribers of PARP inhibitors from the manufacturers were significantly associated with increased prescriptions and Medicare expenditures for olaparib and rucaparib in the United States." @default.
• W4386048136 created "2023-08-23" @default.
• W4386048136 creator A5040680151 @default.
• W4386048136 date "2023-08-22" @default.
• W4386048136 modified "2023-09-25" @default.
• W4386048136 title "Association between pharmaceutical industry payments to physicians and prescription of PARP inhibitors in the United States" @default.
• W4386048136 cites W2083494337 @default.
• W4386048136 cites W2119544755 @default.
• W4386048136 cites W2312780330 @default.
• W4386048136 cites W2319496023 @default.
• W4386048136 cites W2610800273 @default.
• W4386048136 cites W2759900990 @default.
• W4386048136 cites W2777898394 @default.
• W4386048136 cites W2806680042 @default.
• W4386048136 cites W2886477543 @default.
• W4386048136 cites W2890678077 @default.
• W4386048136 cites W2893889285 @default.
• W4386048136 cites W2920495584 @default.
• W4386048136 cites W2925017121 @default.
• W4386048136 cites W2936776369 @default.
• W4386048136 cites W2947826965 @default.
• W4386048136 cites W2951058429 @default.
• W4386048136 cites W2990167158 @default.
• W4386048136 cites W3020771563 @default.
• W4386048136 cites W3096200074 @default.
• W4386048136 cites W3107224684 @default.
• W4386048136 cites W3107325929 @default.
• W4386048136 cites W3114970320 @default.
• W4386048136 cites W3115054311 @default.
• W4386048136 cites W3118356498 @default.
• W4386048136 cites W3165257978 @default.
• W4386048136 cites W3176619044 @default.
• W4386048136 cites W4289830718 @default.
• W4386048136 cites W4291115476 @default.
• W4386048136 cites W4294771023 @default.
• W4386048136 cites W4294982904 @default.
• W4386048136 cites W4297021341 @default.
• W4386048136 cites W4298394617 @default.
• W4386048136 cites W4313596701 @default.
• W4386048136 cites W4366609974 @default.
• W4386048136 doi "https://doi.org/10.21203/rs.3.rs-3280055/v1" @default.
• W4386048136 hasPublicationYear "2023" @default.
• W4386048136 type Work @default.
• W4386048136 citedByCount "0" @default.
• W4386048136 crossrefType "posted-content" @default.
• W4386048136 hasAuthorship W4386048136A5040680151 @default.
• W4386048136 hasBestOaLocation W43860481361 @default.
• W4386048136 hasConcept C10138342 @default.
• W4386048136 hasConcept C104317684 @default.
• W4386048136 hasConcept C121955636 @default.
• W4386048136 hasConcept C126322002 @default.
• W4386048136 hasConcept C143095724 @default.
• W4386048136 hasConcept C144133560 @default.
• W4386048136 hasConcept C145097563 @default.
• W4386048136 hasConcept C151956035 @default.
• W4386048136 hasConcept C156957248 @default.
• W4386048136 hasConcept C162118730 @default.
• W4386048136 hasConcept C182979987 @default.
• W4386048136 hasConcept C2426938 @default.
• W4386048136 hasConcept C2776291444 @default.
• W4386048136 hasConcept C2778858636 @default.
• W4386048136 hasConcept C2778979077 @default.
• W4386048136 hasConcept C2779962180 @default.
• W4386048136 hasConcept C512399662 @default.
• W4386048136 hasConcept C54355233 @default.
• W4386048136 hasConcept C71924100 @default.
• W4386048136 hasConcept C82381507 @default.
• W4386048136 hasConcept C86803240 @default.
• W4386048136 hasConcept C98274493 @default.
• W4386048136 hasConceptScore W4386048136C10138342 @default.
• W4386048136 hasConceptScore W4386048136C104317684 @default.
• W4386048136 hasConceptScore W4386048136C121955636 @default.
• W4386048136 hasConceptScore W4386048136C126322002 @default.
• W4386048136 hasConceptScore W4386048136C143095724 @default.
• W4386048136 hasConceptScore W4386048136C144133560 @default.
• W4386048136 hasConceptScore W4386048136C145097563 @default.
• W4386048136 hasConceptScore W4386048136C151956035 @default.
• W4386048136 hasConceptScore W4386048136C156957248 @default.
• W4386048136 hasConceptScore W4386048136C162118730 @default.
• W4386048136 hasConceptScore W4386048136C182979987 @default.
• W4386048136 hasConceptScore W4386048136C2426938 @default.
• W4386048136 hasConceptScore W4386048136C2776291444 @default.
• W4386048136 hasConceptScore W4386048136C2778858636 @default.
• W4386048136 hasConceptScore W4386048136C2778979077 @default.
• W4386048136 hasConceptScore W4386048136C2779962180 @default.
• W4386048136 hasConceptScore W4386048136C512399662 @default.
• W4386048136 hasConceptScore W4386048136C54355233 @default.
• W4386048136 hasConceptScore W4386048136C71924100 @default.
• W4386048136 hasConceptScore W4386048136C82381507 @default.
• W4386048136 hasConceptScore W4386048136C86803240 @default.
• W4386048136 hasConceptScore W4386048136C98274493 @default.
• W4386048136 hasLocation W43860481361 @default.
• W4386048136 hasOpenAccess W4386048136 @default.
• W4386048136 hasPrimaryLocation W43860481361 @default.
• W4386048136 hasRelatedWork W1993555144 @default.
• W4386048136 hasRelatedWork W2015191509 @default.
• W4386048136 hasRelatedWork W2037611947 @default.
• W4386048136 hasRelatedWork W2102363218 @default.
• W4386048136 hasRelatedWork W2164301666 @default.
• W4386048136 hasRelatedWork W2411462715 @default.

• next